| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |